Fintel reports that on November 26, 2024, Evercore ISI Group upgraded their outlook for Zoom Video Communications ...

In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...

Evercore ISI analyst Chris McNally maintained a Buy rating on Aptiv (APTV – Research Report) today and set a price target of $105.00. The ...

CrowdStrike (CRWD) shares slipped 1% on Monday, even as investment firm Evercore ISI upped its price target on the ...

Fintel reports that on November 22, 2024, Evercore ISI Group initiated coverage of Life Time Group Holdings (NYSE:LTH) with a ...

Investing.com -- Dell Technologies has been added to Evercore ISI's Tactical Outperform list ahead of its October-quarter ...

Evercore ISI highlighted Dell (NYSE:DELL)'s potential to exceed consensus revenue and EPS estimates of $24.69 billion and $2.07, respectively, citing robust performance in storage, general-purpose ...

We recently published a list of 15 AI News You Should Pay Attention To. In this article, we are going to take a look at where ...

is scheduled to participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, Dec. 3, 2024, ...

On Friday, Evercore ISI initiated coverage on Life Time Group Holdings Inc (NYSE: NYSE:LTH) stock, assigning the fitness company an Outperform rating and establishing a price target of $29.00.

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 7th ...

Dell Technologies was added to the Evercore ISI Tactical Outperform list ahead of its third quarter fiscal 2025 financial ...